Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.3M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 19 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Jul 1 | HALO | Halozyme Therapeutics,… | SSELL◷ | 1,000 | $76.40 | $76.4K | -2.3% | Open the original filing on SEC.gov |
| Jun 17 | EDIT | Editas Medicine, Inc. | AGRANT◆ | 51,700 | — | — | — | Open the original filing on SEC.gov |
| Jun 1 | HALO | Halozyme Therapeutics,… | SSELL◷ | 1,625 | $66.21 | $107.6K | -3.6% | Open the original filing on SEC.gov |
| May 5 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 6,040 | — | — | — | Open the original filing on SEC.gov |
| May 5 | HALO | Halozyme Therapeutics,… | AGRANT | 6,796 | — | — | +17.6% | Open the original filing on SEC.gov |
| May 1 | HALO | Halozyme Therapeutics,… | SSELL◷ | 1,625 | $63.48 | $103.2K | -4.0% | Open the original filing on SEC.gov |
| Jan 5 | HALO | Halozyme Therapeutics,… | SSELL◷ | 2,000 | $70.25 | $140.5K | -4.8% | Open the original filing on SEC.gov |
| Dec 1, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 829 | $71.60 | $59.4K | -1.9% | Open the original filing on SEC.gov |
| Nov 10, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 2,000 | $68.48 | $137K | -4.5% | Open the original filing on SEC.gov |
| Oct 1, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 500 | $75.70 | $37.9K | -1.1% | Open the original filing on SEC.gov |
| Oct 1, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 1,500 | $75.09 | $112.6K | -3.2% | Open the original filing on SEC.gov |
| Sep 2, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 923 | $74.11 | $68.4K | -1.9% | Open the original filing on SEC.gov |
| Sep 2, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 2,977 | $73.62 | $219.2K | -5.9% | Open the original filing on SEC.gov |
| Sep 2, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 100 | $71.71 | $7.2K | -0.2% | Open the original filing on SEC.gov |
| Jun 6, 2025 | EDIT | Editas Medicine, Inc. | AGRANT◆ | 37,500 | — | — | — | Open the original filing on SEC.gov |
| May 1, 2025 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 5,750 | — | — | — | Open the original filing on SEC.gov |
| May 1, 2025 | HALO | Halozyme Therapeutics,… | AGRANT | 4,165 | — | — | +8.9% | Open the original filing on SEC.gov |